Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th

 

AUSTIN, Texas, August 1, 2017 — Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri, President and Chief Executive Officer, will provide a corporate overview at the Canaccord Genuity 37th Annual Growth Conference, being held August 9-10 in Boston, Massachusetts.

Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th

Presentation Details

Date:                           Thursday, August 10

Time:                          1:00pm Eastern Time

Location:                    InterContinental Boston Hotel, Hong Kong Room

 

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with critical disease improve their overall health outcomes.

 

Investor Relations Contact:

Michael Wood

LifeSci Advisors LLC

646-597-6983

mwood@lifesciadvisors.com